Weizhuo Zhiyuan

Beijing Weizhuo Zhiyuan Medical Technology has established itself as a specialized provider of intelligent surgical solutions, combining orthopedic navigation robotics with advanced medical imaging systems. The company holds designations as a National Specialized and Sophisticated SME (“Little Giant”) and Beijing Potential Unicorn Enterprise.

Company Overview

Founded in 2016 in Beijing’s Fengtai District, Weizhuo Zhiyuan focuses on digital-intelligent surgical equipment and medical imaging interaction systems. The company emerged from the intersection of clinical expertise and engineering innovation, with founding team members bringing backgrounds from leading institutions including PLA General Hospital (301 Hospital) and Tsinghua University’s computer science department.

Founder and Chairman Lu Tong brings over 20 years of experience in minimally invasive tumor treatment and surgical robot research, holding doctoral credentials in medical imaging from 301 Hospital. The company maintains deep partnerships with the National Clinical Research Center for Orthopedics and Sports Medicine Rehabilitation and the Chinese Geriatrics Society.

In February 2022, Weizhuo Zhiyuan completed a Series A financing round exceeding CNY 100 million, led by China Merchants Capital with participation from Longfor Summit Ventures. Previous investors including Legend Capital, Yuanju Capital, and Zhuoxiang Technology continued their support.

Core Products

Smart Orthopedic Surgery Navigation Robot System

The company’s flagship product provides intelligent surgical navigation for orthopedic procedures, particularly in spine and trauma surgery. The system features 2D-3D registration capabilities, enabling real-time surgical guidance with reduced radiation exposure. Key technical achievements include intelligent image segmentation, AI-powered multimodal image registration, and mixed reality visualization.

Medical Imaging Interaction System (Star Series)

Weizhuo Zhiyuan’s Star Series comprises four MR-based medical visualization products:

• Xingying (Star Shadow): 3D image display system for diagnostic reference using HoloLens integration
• Xingtu (Star Map): Holographic imaging for surgical planning, medical education, and patient communication
• Xinghang (Star Navigation): Intelligent holographic navigation system for real-time surgical instrument tracking
• Xingyun (Star Cloud): Online mixed reality collaboration platform for remote medical consultation

Yuepianbao (Reading Tablet)

Developed in partnership with Huawei, this intelligent medical imaging system converts 2D medical images into 3D models, enabling surgical simulation and remote consultation capabilities. The product has been deployed at PLA General Hospital.

Technology & Innovation

Weizhuo Zhiyuan has achieved breakthroughs in several core technologies:

• 3D reconstruction and intelligent image segmentation
• AI multimodal fusion image registration
• Mixed reality (MR) visualization for medical applications
• Dual-eye stereoscopic vision technology
• Surgical simulation and spatial positioning

The company holds over 200 patents and software copyrights, including 29 invention patents and 24 utility model patents. Weizhuo Zhiyuan participates in national-level research projects including the Ministry of Science and Technology’s National Key R&D Programs for femoral neck fracture treatment and laparoscopic surgical robot development.

Market Presence

The company’s intelligent surgical systems have been deployed across more than 300 hospitals in China, with over 5,000 completed surgical procedures. Clinical feedback indicates improved surgical success rates and reduced postoperative complication rates.

Weizhuo Zhiyuan has collaborated with over 30 top-tier hospitals across 15 clinical departments including cardiac surgery and neurosurgery. The company is establishing international presence through partnerships with the Swiss Academy of Engineering Sciences and international medical education initiatives.

Key Milestones

• 2016: Company founded in Beijing Fengtai District
• 2020: Partnered with Huawei on contactless real-time interactive system during COVID-19
• 2022: Completed Series A financing exceeding CNY 100 million
• 2024: Listed on NEEQ (New Third Board) under code 874156
• 2024: Established Sino-Swiss Medical Health International Innovation Platform

Frequently Asked Questions

What products does Weizhuo Zhiyuan offer?

Weizhuo Zhiyuan provides smart orthopedic surgery navigation robot systems, medical imaging interaction systems (Star Series with four products), and surgical energy and power systems. The company’s solutions cover preoperative planning, intraoperative navigation, and remote consultation.

Is Weizhuo Zhiyuan publicly traded?

Yes, Weizhuo Zhiyuan is listed on China’s NEEQ (National Equities Exchange and Quotations, also known as the New Third Board) under stock code 874156.

What makes Weizhuo Zhiyuan’s technology distinctive?

The company specializes in mixed reality medical visualization, enabling surgeons to interact with 3D holographic patient images during procedures. Their systems achieve “zero fluoroscopy” operation through advanced 2D-3D registration technology, reducing radiation exposure for both patients and medical staff.